List of Tables
Table 1. mRNA Vaccine and Therapeutics Raw Material Market Trends
Table 2. mRNA Vaccine and Therapeutics Raw Material Market Drivers & Opportunity
Table 3. mRNA Vaccine and Therapeutics Raw Material Market Challenges
Table 4. mRNA Vaccine and Therapeutics Raw Material Market Restraints
Table 5. Global mRNA Vaccine and Therapeutics Raw Material Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global mRNA Vaccine and Therapeutics Raw Material Revenue Market Share by Company (2019-2024)
Table 7. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market mRNA Vaccine and Therapeutics Raw Material Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers mRNA Vaccine and Therapeutics Raw Material Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers mRNA Vaccine and Therapeutics Raw Material Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of mRNA Vaccine and Therapeutics Raw Material
Table 13. Global mRNA Vaccine and Therapeutics Raw Material Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine and Therapeutics Raw Material as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global mRNA Vaccine and Therapeutics Raw Material Price by Type (2019-2024) & (US$/Unit)
Table 27. Global mRNA Vaccine and Therapeutics Raw Material Price by Type (2025-2030) & (US$/Unit)
Table 28. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global mRNA Vaccine and Therapeutics Raw Material Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global mRNA Vaccine and Therapeutics Raw Material Price by Application (2019-2024) & (US$/Unit)
Table 39. Global mRNA Vaccine and Therapeutics Raw Material Price by Application (2025-2030) & (US$/Unit)
Table 40. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Region (2019-2024) & (%)
Table 44. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Region (2025-2030) & (%)
Table 45. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Region (2019-2024) & (%)
Table 49. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Region (2025-2030) & (%)
Table 50. Global mRNA Vaccine and Therapeutics Raw Material Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global mRNA Vaccine and Therapeutics Raw Material Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions mRNA Vaccine and Therapeutics Raw Material Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions mRNA Vaccine and Therapeutics Raw Material Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions mRNA Vaccine and Therapeutics Raw Material Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions mRNA Vaccine and Therapeutics Raw Material Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions mRNA Vaccine and Therapeutics Raw Material Sales Volume, (2025-2030) & (K Units)
Table 57. Jena Bioscience Company Information
Table 58. Jena Bioscience Introduction and Business Overview
Table 59. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 61. Jena Bioscience Recent Development
Table 62. Thermo Fisher Scientific Inc. Company Information
Table 63. Thermo Fisher Scientific Inc. Introduction and Business Overview
Table 64. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 66. Thermo Fisher Scientific Inc. Recent Development
Table 67. SBS Genetech Company Information
Table 68. SBS Genetech Introduction and Business Overview
Table 69. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 71. SBS Genetech Recent Development
Table 72. Sigma Aldrich Company Information
Table 73. Sigma Aldrich Introduction and Business Overview
Table 74. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 76. Sigma Aldrich Recent Development
Table 77. Moderna Therapeutics Company Information
Table 78. Moderna Therapeutics Introduction and Business Overview
Table 79. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 81. Moderna Therapeutics Recent Development
Table 82. CureVac Company Information
Table 83. CureVac Introduction and Business Overview
Table 84. CureVac mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. CureVac mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 86. CureVac Recent Development
Table 87. Translate Bio Company Information
Table 88. Translate Bio Introduction and Business Overview
Table 89. Translate Bio mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Translate Bio mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 91. Translate Bio Recent Development
Table 92. BioNTech Company Information
Table 93. BioNTech Introduction and Business Overview
Table 94. BioNTech mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. BioNTech mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 96. BioNTech Recent Development
Table 97. Sangamo Therapeutics Company Information
Table 98. Sangamo Therapeutics Introduction and Business Overview
Table 99. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 101. Sangamo Therapeutics Recent Development
Table 102. Argos Therapeutics Company Information
Table 103. Argos Therapeutics Introduction and Business Overview
Table 104. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 106. Argos Therapeutics Recent Development
Table 107. In-Cell-Art Company Information
Table 108. In-Cell-Art Introduction and Business Overview
Table 109. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 111. In-Cell-Art Recent Development
Table 112. Etherna Company Information
Table 113. Etherna Introduction and Business Overview
Table 114. Etherna mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Etherna mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 116. Etherna Recent Development
Table 117. Ethris Company Information
Table 118. Ethris Introduction and Business Overview
Table 119. Ethris mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Ethris mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 121. Ethris Recent Development
Table 122. Tiba Biotechnology Company Information
Table 123. Tiba Biotechnology Introduction and Business Overview
Table 124. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 126. Tiba Biotechnology Recent Development
Table 127. Product Type Insights Company Information
Table 128. Product Type Insights Introduction and Business Overview
Table 129. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product Offerings
Table 131. Product Type Insights Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. mRNA Vaccine and Therapeutics Raw Material Downstream Customers
Table 135. mRNA Vaccine and Therapeutics Raw Material Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccine and Therapeutics Raw Material Product Picture
Figure 2. Global mRNA Vaccine and Therapeutics Raw Material Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global mRNA Vaccine and Therapeutics Raw Material Sales Value (2019-2030) & (US$ Million)
Figure 4. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume (2019-2030) & (K Units)
Figure 5. Global mRNA Vaccine and Therapeutics Raw Material Sales Price (2019-2030) & (US$/Unit)
Figure 6. mRNA Vaccine and Therapeutics Raw Material Report Years Considered
Figure 7. Global mRNA Vaccine and Therapeutics Raw Material Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global mRNA Vaccine and Therapeutics Raw Material Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by mRNA Vaccine and Therapeutics Raw Material Revenue in 2023
Figure 10. mRNA Vaccine and Therapeutics Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Infectious Disease Vaccines Picture
Figure 12. Cancer Vaccine Picture
Figure 13. Others Picture
Figure 14. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global mRNA Vaccine and Therapeutics Raw Material Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global mRNA Vaccine and Therapeutics Raw Material Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Hospitals and Clinics
Figure 20. Product Picture of Outpatient and Surgery Centers
Figure 21. Product Picture of Others
Figure 22. Global mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global mRNA Vaccine and Therapeutics Raw Material Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global mRNA Vaccine and Therapeutics Raw Material Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global mRNA Vaccine and Therapeutics Raw Material Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America mRNA Vaccine and Therapeutics Raw Material Sales Value (2019-2030) & (US$ Million)
Figure 28. North America mRNA Vaccine and Therapeutics Raw Material Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe mRNA Vaccine and Therapeutics Raw Material Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe mRNA Vaccine and Therapeutics Raw Material Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific mRNA Vaccine and Therapeutics Raw Material Sales Value by Country (%), 2023 VS 2030
Figure 33. South America mRNA Vaccine and Therapeutics Raw Material Sales Value (2019-2030) & (US$ Million)
Figure 34. South America mRNA Vaccine and Therapeutics Raw Material Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa mRNA Vaccine and Therapeutics Raw Material Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions mRNA Vaccine and Therapeutics Raw Material Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions mRNA Vaccine and Therapeutics Raw Material Sales Volume (%), (2019-2030)
Figure 39. United States mRNA Vaccine and Therapeutics Raw Material Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (%), 2023 VS 2030
Figure 41. United States mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe mRNA Vaccine and Therapeutics Raw Material Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (%), 2023 VS 2030
Figure 45. China mRNA Vaccine and Therapeutics Raw Material Sales Value, (2019-2030) & (US$ Million)
Figure 46. China mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (%), 2023 VS 2030
Figure 47. China mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan mRNA Vaccine and Therapeutics Raw Material Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea mRNA Vaccine and Therapeutics Raw Material Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (%), 2023 VS 2030
Figure 57. India mRNA Vaccine and Therapeutics Raw Material Sales Value, (2019-2030) & (US$ Million)
Figure 58. India mRNA Vaccine and Therapeutics Raw Material Sales Value by Type (%), 2023 VS 2030
Figure 59. India mRNA Vaccine and Therapeutics Raw Material Sales Value by Application (%), 2023 VS 2030
Figure 60. mRNA Vaccine and Therapeutics Raw Material Industrial Chain
Figure 61. mRNA Vaccine and Therapeutics Raw Material Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
